首页> 外文期刊>Neuro-Oncology >The transcription factor Olig2 is important for the biology of diffuse intrinsic pontine gliomas
【24h】

The transcription factor Olig2 is important for the biology of diffuse intrinsic pontine gliomas

机译:转录因子Olig2对弥漫性桥脑神经胶质瘤的生物学作用很重要

获取原文
获取原文并翻译 | 示例
           

摘要

Background. Diffuse intrinsic pontine glioma (DIPG) is a high-grade brainstem glioma of children with dismal prognosis. There is no single unifying model about the cell of origin of DIPGs. Proliferating cells in the developing human and mouse pons, the site of DIPGs, express neural stem/progenitor cell (NPC) markers, including Sox2, nestin, vimentin, Olig2, and glial fibrillary acidic protein, in an overlapping and non-overlapping manner, suggesting progenitor cell heterogeneity in the pons. It is thought that during a restricted window of postnatal pons development, a differentiation block caused by genetic/epigenetic changes leads to unrestrained progenitor proliferation and DIPG development. Nearly 80% of DIPGs harbor a mutation in the H3F3A or the related HIST1H3B gene. Supporting the impaired differentiation model, NPCs derived from human induced pluripotent stem cells expressing the H3F3A mutation showed complete differentiation block. However, the mechanisms regulating an altered differentiation program in DIPG are unknown.
机译:背景。弥漫性桥脑神经胶质瘤(DIPG)是儿童预后不良的高级脑干神经胶质瘤。关于DIPG的起源细胞,没有单一的统一模型。处于发育中的人类和小鼠脑桥(DIPG的位点)中的增殖细胞以重叠和非重叠的方式表达神经干/祖细胞(NPC)标记,包括Sox2,nestin,波形蛋白,Olig2和神经胶质纤维酸性蛋白,提示pons中的祖细胞异质性。据认为,在出生后脑桥发育的受限窗口期间,由遗传/表观遗传学变化引起的分化障碍导致不受限制的祖细胞增殖和DIPG的发育。接近80%的DIPG含有H3F3A或相关HIST1H3B基因的突变。支持受损的分化模型,表达H3F3A突变的人诱导多能干细胞衍生的NPC显示出完全的分化阻滞。然而,尚不清楚调节DIPG中分化程序改变的机制。

著录项

  • 来源
    《Neuro-Oncology》 |2017年第8期|1068-1078|共11页
  • 作者单位

    Cincinnati Childrens Hosp Med Ctr, Div Oncol, Ctr Autoimmune Genom & Etiol & Biomed Informat, Cincinnati, OH 45229 USA;

    Cincinnati Childrens Hosp Med Ctr, Div Oncol, Ctr Autoimmune Genom & Etiol & Biomed Informat, Cincinnati, OH 45229 USA;

    Cincinnati Childrens Hosp Med Ctr, Div Oncol, Ctr Autoimmune Genom & Etiol & Biomed Informat, Cincinnati, OH 45229 USA;

    Cincinnati Childrens Hosp Med Ctr, Div Oncol, Ctr Autoimmune Genom & Etiol & Biomed Informat, Cincinnati, OH 45229 USA;

    Cincinnati Childrens Hosp Med Ctr, Expt Hematol & Canc Biol, Ctr Autoimmune Genom & Etiol & Biomed Informat, Cincinnati, OH 45229 USA;

    Cincinnati Childrens Hosp Med Ctr, Expt Hematol & Canc Biol, Ctr Autoimmune Genom & Etiol & Biomed Informat, Cincinnati, OH 45229 USA;

    Cincinnati Childrens Hosp Med Ctr, Div Oncol, Ctr Autoimmune Genom & Etiol & Biomed Informat, Cincinnati, OH 45229 USA;

    Cincinnati Childrens Hosp Med Ctr, Pathol, Ctr Autoimmune Genom & Etiol & Biomed Informat, Cincinnati, OH 45229 USA|Nemours Childrens Hosp, Orlando, FL USA;

    Johns Hopkins Univ, Div Pediat Oncol, Baltimore, MD USA;

    Cincinnati Childrens Hosp Med Ctr, Dev Biol, Ctr Autoimmune Genom & Etiol & Biomed Informat, Cincinnati, OH 45229 USA;

    Cincinnati Childrens Hosp Med Ctr, Div Oncol, Ctr Autoimmune Genom & Etiol & Biomed Informat, Cincinnati, OH 45229 USA;

    Cincinnati Childrens Hosp Med Ctr, Div Oncol, Ctr Autoimmune Genom & Etiol & Biomed Informat, Cincinnati, OH 45229 USA;

    Cincinnati Childrens Hosp Med Ctr, Div Oncol, Ctr Autoimmune Genom & Etiol & Biomed Informat, Cincinnati, OH 45229 USA;

    Cincinnati Childrens Hosp Med Ctr, Div Oncol, Ctr Autoimmune Genom & Etiol & Biomed Informat, Cincinnati, OH 45229 USA;

    Cincinnati Childrens Hosp Med Ctr, Div Oncol, Ctr Autoimmune Genom & Etiol & Biomed Informat, Cincinnati, OH 45229 USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    differentiation; DIPG; Olig2;

    机译:分化;DIPG;Olig2;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号